Cargando…
IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
BACKGROUND: Studies from our laboratory and others have shown that cysteine-rich 61 (Cyr61) may be involved in tumor proliferation and invasion. In earlier studies, we demonstrated increased insulin-like growth factor-I (IGF-1) is associated with breast tumor formation and poor clinical outcomes. In...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111618/ https://www.ncbi.nlm.nih.gov/pubmed/25062088 http://dx.doi.org/10.1371/journal.pone.0103534 |
_version_ | 1782328110166835200 |
---|---|
author | Sarkissyan, Suren Sarkissyan, Marianna Wu, Yanyuan Cardenas, Jessica Koeffler, H. Phillip Vadgama, Jaydutt V. |
author_facet | Sarkissyan, Suren Sarkissyan, Marianna Wu, Yanyuan Cardenas, Jessica Koeffler, H. Phillip Vadgama, Jaydutt V. |
author_sort | Sarkissyan, Suren |
collection | PubMed |
description | BACKGROUND: Studies from our laboratory and others have shown that cysteine-rich 61 (Cyr61) may be involved in tumor proliferation and invasion. In earlier studies, we demonstrated increased insulin-like growth factor-I (IGF-1) is associated with breast tumor formation and poor clinical outcomes. In our current study we have investigated IGF-1 regulation of Cyr61 and whether targeting IGF-1 could inhibit Cyr61 induced tumor growth and proliferation. METHODS: Several ATCC derived normal and breast cancer cell lines were used in this study: MDA-MB231, BT474, MCF-7, and SKBR3. We also tested cells stably transfected in our laboratory with active Akt1 (pAkt; SKBR3/AA and MCF-7/AA) and dominant negative Akt1 (SKBR3/DN and MCF-7/DN). In addition, we used MCF-7 cells transfected with full length Cyr61 (CYA). Monolayer cultures treated with IGF-1 were analyzed for Cyr61 expression by RT-PCR and immunohistochemical staining. Migration assays and MTT based proliferation assays were used to determine invasive characteristics in response to IGF-1/Cyr61 activation. RESULTS: Cells with activated Akt have increased levels of Cyr61. Conversely, cells with inactive Akt have decreased levels of Cyr61. IGF-1 treatment increased Cyr61 expression significantly and cells with high level of Cyr61 demonstrate increased invasiveness and proliferation. Cyr61 overexpression and activation led to decrease in E-cadherin and decrease in FOXO1. Inhibition of the PI3K and MAPK pathways resulted in significant decrease in invasiveness and proliferation, most notably in the PI3K pathway inhibited cells. CONCLUSION: The findings of this study show that IGF-1 upregulates Cyr61 primarily through activation of the Akt-PI3K pathway. IGF-1 induced MAPK plays a partial role. Increase in Cyr61 leads to increase in breast cancer cell growth and invasion. Hence, targeting Cyr61 and associated pathways may offer an opportunity to inhibit IGF-1 mediated Cyr61 induced breast cancer growth and invasion. |
format | Online Article Text |
id | pubmed-4111618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41116182014-07-29 IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion Sarkissyan, Suren Sarkissyan, Marianna Wu, Yanyuan Cardenas, Jessica Koeffler, H. Phillip Vadgama, Jaydutt V. PLoS One Research Article BACKGROUND: Studies from our laboratory and others have shown that cysteine-rich 61 (Cyr61) may be involved in tumor proliferation and invasion. In earlier studies, we demonstrated increased insulin-like growth factor-I (IGF-1) is associated with breast tumor formation and poor clinical outcomes. In our current study we have investigated IGF-1 regulation of Cyr61 and whether targeting IGF-1 could inhibit Cyr61 induced tumor growth and proliferation. METHODS: Several ATCC derived normal and breast cancer cell lines were used in this study: MDA-MB231, BT474, MCF-7, and SKBR3. We also tested cells stably transfected in our laboratory with active Akt1 (pAkt; SKBR3/AA and MCF-7/AA) and dominant negative Akt1 (SKBR3/DN and MCF-7/DN). In addition, we used MCF-7 cells transfected with full length Cyr61 (CYA). Monolayer cultures treated with IGF-1 were analyzed for Cyr61 expression by RT-PCR and immunohistochemical staining. Migration assays and MTT based proliferation assays were used to determine invasive characteristics in response to IGF-1/Cyr61 activation. RESULTS: Cells with activated Akt have increased levels of Cyr61. Conversely, cells with inactive Akt have decreased levels of Cyr61. IGF-1 treatment increased Cyr61 expression significantly and cells with high level of Cyr61 demonstrate increased invasiveness and proliferation. Cyr61 overexpression and activation led to decrease in E-cadherin and decrease in FOXO1. Inhibition of the PI3K and MAPK pathways resulted in significant decrease in invasiveness and proliferation, most notably in the PI3K pathway inhibited cells. CONCLUSION: The findings of this study show that IGF-1 upregulates Cyr61 primarily through activation of the Akt-PI3K pathway. IGF-1 induced MAPK plays a partial role. Increase in Cyr61 leads to increase in breast cancer cell growth and invasion. Hence, targeting Cyr61 and associated pathways may offer an opportunity to inhibit IGF-1 mediated Cyr61 induced breast cancer growth and invasion. Public Library of Science 2014-07-25 /pmc/articles/PMC4111618/ /pubmed/25062088 http://dx.doi.org/10.1371/journal.pone.0103534 Text en © 2014 Sarkissyan et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sarkissyan, Suren Sarkissyan, Marianna Wu, Yanyuan Cardenas, Jessica Koeffler, H. Phillip Vadgama, Jaydutt V. IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion |
title | IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion |
title_full | IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion |
title_fullStr | IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion |
title_full_unstemmed | IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion |
title_short | IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion |
title_sort | igf-1 regulates cyr61 induced breast cancer cell proliferation and invasion |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111618/ https://www.ncbi.nlm.nih.gov/pubmed/25062088 http://dx.doi.org/10.1371/journal.pone.0103534 |
work_keys_str_mv | AT sarkissyansuren igf1regulatescyr61inducedbreastcancercellproliferationandinvasion AT sarkissyanmarianna igf1regulatescyr61inducedbreastcancercellproliferationandinvasion AT wuyanyuan igf1regulatescyr61inducedbreastcancercellproliferationandinvasion AT cardenasjessica igf1regulatescyr61inducedbreastcancercellproliferationandinvasion AT koefflerhphillip igf1regulatescyr61inducedbreastcancercellproliferationandinvasion AT vadgamajayduttv igf1regulatescyr61inducedbreastcancercellproliferationandinvasion |